• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    7/10/23 12:34:28 PM ET
    $AAN
    $ADN
    $ALPP
    $ARAV
    Diversified Commercial Services
    Consumer Discretionary
    Industrial Machinery/Components
    Miscellaneous
    Get the next $AAN alert in real time by email

    Gainers

    • Mobilicom Limited (NASDAQ:MOB) shares jumped 81.3% to $2.7187 after the company announced it received a commercial scale purchase order from Teledyne-FLIR for the production of drones for the U.S. Department of Defense.
    • Nanobiotix S.A. (NASDAQ:NBTX) shares jumped 45.5% to $7.32 after the company entered into a license agreement with Janssen Pharmaceutical for global co-development and commercialization of NBTXR3.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) shares rose 36% to $0.1565 after gaining over 38% on Friday.
    • Jupiter Wellness, Inc. (NASDAQ:JUPW) gained 34.8% to $0.4934 after the company announced it has executed an Asset Purchase Agreement with GBB Drink Lab to acquire all operating assets including the "Safety Shot" rapid alcohol detox drink.
    • NanoString Technologies, Inc. (NASDAQ:NSTG) shares gained 32.4% to $4.90 after the company said it expects second-quarter revenue to be over $44 million, above the upper end of its guidance range and the $41 million consensus estimate. The company also reiterated FY23 revenue guidance above the consensus estimate.
    • Gorilla Technology Group Inc. (NASDAQ:GRRR) gained 30.8% to $6.15. Gorilla Technology shares jumped 125% on Friday after the company signed a $270 million contract with the Government of Egypt to implement a Smart Government Security Convergence solution.
    • Shineco, Inc. (NASDAQ:SISI) gained 28.5% to $0.4165 after the company announced its subsidiary received marketing and distribution approval for its Cardiac 5-Minute Test from the Jiangsu Bureau of China's National Medical Products Administration.
    • Alpine 4 Holdings, Inc. (NASDAQ:ALPP) shares rose 22% to $2.05 after the company said its subsidiary, Vayu Aerospace Corporation, received its first $5.25m purchase order from its $100 million supply agreement with U.S. Government contractor, All American Contracting, Inc.
    • Novavax, Inc. (NASDAQ:NVAX) gained 21.2% to $8.77. The European Commission recently approved Novavax’s Nuvaxovid (NVX-CoV2373), following a positive opinion for a full authorization from the Committee for Medicinal Products for Human Use of the European Medicines Agency.
    • Marker Therapeutics, Inc. (NASDAQ:MRKR) rose 19.8% to $5.20 after the company announced the European Medicines Agency granted MT-401 an Orphan Drug Designation.
    • NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) gained 19% to $1.44.
    • Icahn Enterprises L.P. (NASDAQ:IEP) gained 17.8% to $34.02 after Carl Icahn amended loan agreements, disconnecting his personal loans from the share price, increasing his collateral and establishing a plan to repay the loans within three years. This was an issue raised in Hindenburg Research's short report on the stock issued in May.
    • Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) gained 17.5% to $8.51 after the company announced regulatory, clinical updates for TIL therapy in advanced non-small cell lung cancer.
    • SOS Limited (NYSE:SOS) gained 17.4% to $5.31.
    • Aravive, Inc. (NASDAQ:ARAV) climbed 17.4% to $1.55. Cantor Fitzgerald reiterated Aravive with an Overweight and maintained $18 price target.
    • Advent Technologies Holdings, Inc. (NASDAQ:ADN) gained 17.4% to $0.7399.
    • Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) jumped 17% to $3.03.
    • Stronghold Digital Mining, Inc. (NASDAQ:SDIG) gained 16.1% to $8.16.
    • Helen of Troy Limited (NASDAQ:HELE) rose 15.7% to $130.26 after the company reported better-than-expected first-quarter financial results and issued guidance.
    • TMC the metals company Inc. (NASDAQ:TMC) jumped 15.3% to $2.9150 after ThinkEquity initiated coverage on the stock with a Buy rating and announced a $6 price target.
    • fuboTV Inc. (NYSE:FUBO) gained 14.2% to $2.48.
    • Groupon, Inc. (NASDAQ:GRPN) jumped 13.8% to $6.95.
    • Siyata Mobile Inc. (NASDAQ:SYTA) shares climbed 12.9% to $0.07 after gaining around 12% on Friday.
    • Lyft, Inc. (NASDAQ:LYFT) rose 11.2% to $11.26.
    • Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) shares gained 7.6% to $4.7450. Black Diamond Therapeutics Director Rajeev Shah purchased 935,850 shares at an average price of $5.00 per share.

    Losers

    • Tivic Health Systems, Inc. (NASDAQ:TIVC) shares fell 41.4% to $0.0650 after the company priced public offering of 32.5 million shares at $0.055 per share.
    • Neonode Inc. (NASDAQ:NEON) fell 33.8% to $4.85 after dropping over 8% on Friday.
    • ProMIS Neurosciences, Inc. (NASDAQ:PMN) shares dropped 19.7% to $2.81. The company announced plans to voluntarily delist from the Toronto Stock Exchange.
    • Xcel Brands, Inc. (NASDAQ:XELB) dipped 19.4% to $1.16.
    • Nocera, Inc. (NASDAQ:NCRA) dropped 18.4% to $1.6480.
    • Presto Automation Inc. (NASDAQ:PRST) fell 18.1% to $3.49. Rajat Suri, 10% owner at Presto Automation, reported a large insider sell on July 6.
    • Tattooed Chef, Inc. (NASDAQ:TTCF) fell 16.4% to $0.2175.
    • Trinity Place Holdings Inc. (NYSE:TPHS) dropped 14.4% to $0.5481.
    • The Aaron's Company, Inc. (NYSE:AAN) fell 12.2% to $13.41 after Loop Capital downgraded the stock from Buy to Hold.
    • FOXO Technologies Inc. (NYSE:FOXO) dropped 12.2% to $0.18.
    • Metalpha Technology Holding Limited (NASDAQ:MATH) declined 11.8% to $1.27.
    • Shengfeng Development Limited (NASDAQ:SFWL) fell 11.3% to $8.97.
    • FMC Corporation (NYSE:FMC) dropped 11.3% to $92.42 after the company issued weak revenue guidance.
    • Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) fell 10.5% to $3.8899. Biodexa Ltd, subsidiary of Biodexa Pharmaceuticals, has completed the enrolment and treatment of nine pediatric patients in the ongoing Phase 1 study of MTX-110 in newly diagnosed diffuse midline gliomas.
    • SunCar Technology Group Inc. (NASDAQ:SDA) dropped 9.8% to $20.05.
    • MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) declined 9.7% to $1.0470.
    • VOXX International Corporation (NASDAQ:VOXX) fell 8.8% to $11.53.
    • 22nd Century Group, Inc. (NASDAQ:XXII) fell 8.5% to $2.45.
    • Femasys Inc. (NASDAQ:FEMY) fell 7% to $0.4785.

    Now Read This: This Analyst With 83% Accuracy Rate Sees Around 7% Upside In Alphabet - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts

    Get the next $AAN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAN
    $ADN
    $ALPP
    $ARAV

    CompanyDatePrice TargetRatingAnalyst
    FMC Corporation
    $FMC
    4/22/2026$14.00Hold → Sell
    Vertical Research
    Corvus Pharmaceuticals Inc.
    $CRVS
    4/17/2026$40.00Buy
    Goldman
    FuboTV Inc.
    $FUBO
    4/7/2026$16.00Mkt Perform → Outperform
    Barrington Research
    FuboTV Inc.
    $FUBO
    3/30/2026$13.00Mkt Outperform
    Citizens
    FuboTV Inc.
    $FUBO
    3/27/2026$18.00Buy
    B. Riley Securities
    Iovance Biotherapeutics Inc.
    $IOVA
    2/25/2026$5.00Mkt Perform → Mkt Outperform
    Citizens
    Nanobiotix S.A.
    $NBTX
    2/6/2026Buy
    TD Cowen
    FuboTV Inc.
    $FUBO
    2/5/2026$3.00Neutral → Buy
    Seaport Research Partners
    More analyst ratings

    $AAN
    $ADN
    $ALPP
    $ARAV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kirwin Patrick D. bought $45,320 worth of shares (4,000 units at $11.33) (SEC Form 4)

    4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)

    4/23/26 9:25:00 PM ET
    $PMN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Whiteside Janey

    4 - Lyft, Inc. (0001759509) (Issuer)

    4/22/26 8:30:33 PM ET
    $LYFT
    Real Estate

    SEC Form 4 filed by Stephenson Dave

    4 - Lyft, Inc. (0001759509) (Issuer)

    4/22/26 8:28:45 PM ET
    $LYFT
    Real Estate

    $AAN
    $ADN
    $ALPP
    $ARAV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Xcel Brands & Gemma Stafford Launch GemmaMade on QVC

    NEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- Xcel Brands (NASDAQ:XELB), an industry leading media and consumer products company specializing in building influencer-driven brands through social commerce and live streaming, is excited to announce International Baking Star, chef and creator of the YouTube sensation Bigger Bolder Baking, Gemma Stafford, will be premiering GemmaMade by Gemma Stafford on QVC Sunday, April 26th, 2026. For her debut collection, GemmaMade by Gemma Stafford draws inspiration from her Irish heritage, featuring signature kitchen pieces designed to bring the spirit of Ireland into the home. Rooted in her belief that the kitchen is the heart of the home, the collection

    4/24/26 10:00:00 AM ET
    $XELB
    Multi-Sector Companies
    Miscellaneous

    Tivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream Model

    Ticker Symbol to Change from TIVC to VBIO Effective April 28, 2026; Company Advancing Entolimod™ Toward BARDA Funding and Strategic National Stockpile Procurement While Velocity Bioworks CDMO Builds Independent Revenue BaseSAN ANTONIO, April 23, 2026 /PRNewswire/ -- Tivic Health Systems, Inc. (NASDAQ:TIVC) today announced it is changing its corporate name to Valion Bio, Inc. and its Nasdaq ticker symbol from TIVC to VBIO, effective at market open on Tuesday, April 28, 2026. The CUSIP number for the company's common stock will remain unchanged. The rebrand is not merely cosmetic.

    4/23/26 4:05:00 PM ET
    $TIVC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Mobilicom to Exhibit at Modern Day Marine 2026, Showcasing its Cybersecure Solutions Portfolio Amid Growing U.S. Department of War Platform Deployments

    Mobilicom to hold strategic meetings with U.S. Department of War and Marine Corps representatives, as well as existing customers and new customers under integration, at the premier Marine Corps technology exposition Palo Alto, California, April 23, 2026 (GLOBE NEWSWIRE) -- Mobilicom Limited (NASDAQ:MOB, MOBBW)) ("Mobilicom" or the "Company"), a provider of cybersecurity and robust solutions for drones and robotics, today announced it will exhibit at Modern Day Marine 2026, taking place April 28–30, 2026 in Washington, D.C. The Company will exhibit under the booth of its strategic U.S. partner, Noble, a leading provider of procurement and logistics for the defense industry, at Booth #618.

    4/23/26 9:15:00 AM ET
    $MOB
    Aerospace
    Industrials

    $AAN
    $ADN
    $ALPP
    $ARAV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kirwin Patrick D. bought $45,320 worth of shares (4,000 units at $11.33) (SEC Form 4)

    4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)

    4/23/26 9:25:00 PM ET
    $PMN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Williams Eugene bought $48,800 worth of shares (2,000 units at $24.40), increasing direct ownership by 19% to 12,397 units (SEC Form 4)

    4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)

    3/6/26 7:28:00 AM ET
    $PMN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Barry Michael F bought $249,938 worth of shares (18,072 units at $13.83), increasing direct ownership by 1,157% to 19,634 units (SEC Form 4)

    4 - FMC CORP (0000037785) (Issuer)

    3/5/26 12:11:06 PM ET
    $FMC
    Major Chemicals
    Industrials

    $AAN
    $ADN
    $ALPP
    $ARAV
    SEC Filings

    View All

    SEC Form DEF 14A filed by Corvus Pharmaceuticals Inc.

    DEF 14A - Corvus Pharmaceuticals, Inc. (0001626971) (Filer)

    4/24/26 4:15:31 PM ET
    $CRVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEFA14A filed by Corvus Pharmaceuticals Inc.

    DEFA14A - Corvus Pharmaceuticals, Inc. (0001626971) (Filer)

    4/24/26 4:16:27 PM ET
    $CRVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form S-1/A filed by Xcel Brands Inc.

    S-1/A - XCel Brands, Inc. (0001083220) (Filer)

    4/23/26 5:45:26 PM ET
    $XELB
    Multi-Sector Companies
    Miscellaneous

    $AAN
    $ADN
    $ALPP
    $ARAV
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    February 16, 2024 - FDA Approves First Cellular Therapy to Treat Patients with Unresectable or Metastatic Melanoma

    For Immediate Release: February 16, 2024 Today, the U.S. Food and Drug Administration approved Amtagvi, the first cellular therapy indicated for the treatment of adult patients with a type of skin cancer (melanoma) that is unable to be removed with surgery (unresectable) or has spread to other parts of the body (metastatic) that previously has been treated with other therapies (a PD-1 blocking antibody, and if B

    2/16/24 3:48:47 PM ET
    $IOVA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAN
    $ADN
    $ALPP
    $ARAV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    FMC Corp downgraded by Vertical Research with a new price target

    Vertical Research downgraded FMC Corp from Hold to Sell and set a new price target of $14.00

    4/22/26 7:34:40 AM ET
    $FMC
    Major Chemicals
    Industrials

    Goldman initiated coverage on Corvus Pharmaceuticals with a new price target

    Goldman initiated coverage of Corvus Pharmaceuticals with a rating of Buy and set a new price target of $40.00

    4/17/26 8:10:40 AM ET
    $CRVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    fuboTV upgraded by Barrington Research with a new price target

    Barrington Research upgraded fuboTV from Mkt Perform to Outperform and set a new price target of $16.00

    4/7/26 8:16:42 AM ET
    $FUBO
    Movies/Entertainment
    Consumer Discretionary

    $AAN
    $ADN
    $ALPP
    $ARAV
    Leadership Updates

    Live Leadership Updates

    View All

    Xcel Brands & Gemma Stafford Launch GemmaMade on QVC

    NEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- Xcel Brands (NASDAQ:XELB), an industry leading media and consumer products company specializing in building influencer-driven brands through social commerce and live streaming, is excited to announce International Baking Star, chef and creator of the YouTube sensation Bigger Bolder Baking, Gemma Stafford, will be premiering GemmaMade by Gemma Stafford on QVC Sunday, April 26th, 2026. For her debut collection, GemmaMade by Gemma Stafford draws inspiration from her Irish heritage, featuring signature kitchen pieces designed to bring the spirit of Ireland into the home. Rooted in her belief that the kitchen is the heart of the home, the collection

    4/24/26 10:00:00 AM ET
    $XELB
    Multi-Sector Companies
    Miscellaneous

    Corvus Pharmaceuticals Appoints Andrew C. Chan, M.D., Ph.D., to Board of Directors

    SOUTH SAN FRANCISCO, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company, announced today that Andrew C. Chan, M.D., Ph.D., has been appointed to the Company's Board of Directors. Dr. Chan recently served as Senior Vice President, Research Biology during a distinguished 25 year career at Genentech. In this role, he led biological research across all therapeutic areas, contributing to the development of several FDA-approved medicines for oncology, neurology and immunology. "The addition of Dr. Chan elevates the scientific perspective of our Board as we continue to identify and advance opportunities for ITK inhibi

    4/23/26 7:30:00 AM ET
    $CRVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Gorilla Technology Increases Strategic Investment in Astrikos.AI

    - Builds on Q4 investment to further advance Gorilla's integrated AI infrastructure strategy across India, USA, and UAE- Appoints Managing Partner of Gorilla Tech Capital to the board of AstrikosLondon, United Kingdom--(Newsfile Corp. - April 15, 2026) - Gorilla Technology Group Inc. (NASDAQ:GRRR) ("Gorilla" or the "Company"), a global solution provider in AI-driven Security Intelligence, Network Intelligence, Business Intelligence and IoT technology, today announced that it has increased its strategic investment in Astrikos.AI ("Astrikos"), the Bengaluru, India-based, real-time infrastructure intelligence company, deepening the operational and commercial relationship betw

    4/15/26 8:30:00 AM ET
    $GRRR
    Computer Software: Prepackaged Software
    Technology

    $AAN
    $ADN
    $ALPP
    $ARAV
    Financials

    Live finance-specific insights

    View All

    Lyft Expands in London with Gett UK Acquisition

    Key takeaways: Lyft has agreed to acquire Gett's United Kingdom business with close expected in the coming weeks, subject to customary closing conditions. Gett is one of London's leading black cab apps with strong enterprise business-to-business (B2B) relationships, and brings together the majority of Greater London's registered black cab drivers and will nearly double the number of rides on the Lyft platform in London. With Gett, Lyft is expanding its coverage of London's full ground transport ecosystem. This advances Lyft's sustainable global growth strategy, while expanding "out" in more locations and "up" into more high-value segments. Lyft (NASDAQ:LYFT) has agreed to acq

    4/23/26 8:48:00 AM ET
    $LYFT
    Real Estate

    Groupon Announces Date for First Quarter 2026 Financial Results

    Chicago, Illinois--(Newsfile Corp. - April 23, 2026) - Groupon, Inc. (NASDAQ:GRPN) announced today that it intends to release the company's first quarter 2026 financial results after the market closes on Thursday, May 7, 2026. The company will also host a conference call to answer questions regarding the company's results at 8:00am ET on Friday, May 8, 2026. Investors may submit questions by emailing [email protected] webcast of the conference call can be accessed live at investor.groupon.com. A replay of the webcast will be available through the same link following the conference call, along with other published materials.About Groupon Groupon (www.groupon.com) (NASDAQ:GRPN) is a trusted loc

    4/23/26 7:00:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting

    Two oral presentations including late-breaker at SID  Data will cover Phase 1 clinical trial of soquelitinib for atopic dermatitis, including new immunologic and biomarker data supporting drug-free remissions Investor and analyst meeting scheduled for 1:30 pm ET (12:30 pm CT) on May 14, 2026 Company to report first quarter 2026 financial results on May 7, 2026 SOUTH SAN FRANCISCO, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company, announced today that it will host an in-person and virtual investor and analyst meeting on May 14, 2026 to highlight soquelitinib data being presented at the Society for Investiga

    4/21/26 7:30:00 AM ET
    $CRVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAN
    $ADN
    $ALPP
    $ARAV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/13/24 10:39:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Gorilla Technology Group Inc.

    SC 13G/A - Gorilla Technology Group Inc. (0001903145) (Subject)

    12/6/24 9:25:12 PM ET
    $GRRR
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/6/24 2:12:18 PM ET
    $GRPN
    Advertising
    Consumer Discretionary